

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.24518330 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.24518330 |
| 3 | protein retention in ER lumen (GO:0006621) | 5.20902969 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.94026413 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.76845811 |
| 6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.62062775 |
| 7 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.05327005 |
| 8 | GDP-mannose metabolic process (GO:0019673) | 3.99234629 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.90336480 |
| 10 | proline biosynthetic process (GO:0006561) | 3.89016528 |
| 11 | pinocytosis (GO:0006907) | 3.88750568 |
| 12 | DNA deamination (GO:0045006) | 3.87046034 |
| 13 | interferon-gamma production (GO:0032609) | 3.76369204 |
| 14 | sequestering of actin monomers (GO:0042989) | 3.70472360 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 3.69591556 |
| 16 | superoxide anion generation (GO:0042554) | 3.66760209 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.62229116 |
| 18 | negative regulation of mast cell activation (GO:0033004) | 3.50364338 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.49328863 |
| 20 | pentose-phosphate shunt (GO:0006098) | 3.47612657 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 3.43236010 |
| 22 | proteasome assembly (GO:0043248) | 3.41501104 |
| 23 | glycosphingolipid catabolic process (GO:0046479) | 3.38847699 |
| 24 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.37276317 |
| 25 | UV protection (GO:0009650) | 3.35938579 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33195328 |
| 27 | regulation of mast cell activation (GO:0033003) | 3.30050715 |
| 28 | neutrophil activation (GO:0042119) | 3.26756036 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 3.21550339 |
| 30 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.20908636 |
| 31 | termination of RNA polymerase III transcription (GO:0006386) | 3.19469907 |
| 32 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.19469907 |
| 33 | glucose catabolic process (GO:0006007) | 3.18623021 |
| 34 | oligosaccharide catabolic process (GO:0009313) | 3.18107098 |
| 35 | ceramide catabolic process (GO:0046514) | 3.09533102 |
| 36 | protein localization to endosome (GO:0036010) | 3.09521238 |
| 37 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.08428545 |
| 38 | negative regulation of cell size (GO:0045792) | 3.06820585 |
| 39 | apoptotic process involved in morphogenesis (GO:0060561) | 3.06441546 |
| 40 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.06029009 |
| 41 | stress fiber assembly (GO:0043149) | 3.04521573 |
| 42 | basement membrane organization (GO:0071711) | 3.03456633 |
| 43 | peptidyl-proline hydroxylation (GO:0019511) | 3.02286436 |
| 44 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.01059479 |
| 45 | positive regulation of mast cell degranulation (GO:0043306) | 3.00659519 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.00659519 |
| 47 | glycolipid catabolic process (GO:0019377) | 3.00423943 |
| 48 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.99667333 |
| 49 | NADPH regeneration (GO:0006740) | 2.99382444 |
| 50 | signal peptide processing (GO:0006465) | 2.98670976 |
| 51 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.98650307 |
| 52 | dendritic cell chemotaxis (GO:0002407) | 2.95427715 |
| 53 | mitotic nuclear envelope reassembly (GO:0007084) | 2.93146113 |
| 54 | nuclear envelope reassembly (GO:0031468) | 2.93146113 |
| 55 | hyaluronan catabolic process (GO:0030214) | 2.91873472 |
| 56 | skin morphogenesis (GO:0043589) | 2.90389292 |
| 57 | tRNA methylation (GO:0030488) | 2.90044413 |
| 58 | modulation by symbiont of host cellular process (GO:0044068) | 2.88586977 |
| 59 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.86925510 |
| 60 | germinal center formation (GO:0002467) | 2.86090980 |
| 61 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.84477455 |
| 62 | protein hydroxylation (GO:0018126) | 2.83544855 |
| 63 | mannose metabolic process (GO:0006013) | 2.82500127 |
| 64 | granulocyte activation (GO:0036230) | 2.79073251 |
| 65 | natural killer cell activation involved in immune response (GO:0002323) | 2.79061985 |
| 66 | pyrimidine-containing compound salvage (GO:0008655) | 2.79030466 |
| 67 | pyrimidine nucleoside salvage (GO:0043097) | 2.79030466 |
| 68 | 7-methylguanosine mRNA capping (GO:0006370) | 2.78311577 |
| 69 | positive regulation of protein homodimerization activity (GO:0090073) | 2.77869479 |
| 70 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.76822208 |
| 71 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.76601411 |
| 72 | regulation of early endosome to late endosome transport (GO:2000641) | 2.74534794 |
| 73 | response to peptidoglycan (GO:0032494) | 2.73373654 |
| 74 | 7-methylguanosine RNA capping (GO:0009452) | 2.73260906 |
| 75 | RNA capping (GO:0036260) | 2.73260906 |
| 76 | mitochondrial fusion (GO:0008053) | 2.73256187 |
| 77 | 4-hydroxyproline metabolic process (GO:0019471) | 2.72774279 |
| 78 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.72139172 |
| 79 | response to interleukin-15 (GO:0070672) | 2.70220629 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 2.70218448 |
| 81 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.69410885 |
| 82 | modulation by virus of host process (GO:0019054) | 2.68493030 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 2.68453124 |
| 84 | histone arginine methylation (GO:0034969) | 2.68338798 |
| 85 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.67160234 |
| 86 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.65960259 |
| 87 | developmental pigmentation (GO:0048066) | 2.62586947 |
| 88 | cellular response to arsenic-containing substance (GO:0071243) | 2.61203011 |
| 89 | leukocyte aggregation (GO:0070486) | 2.61167719 |
| 90 | pentose metabolic process (GO:0019321) | 2.61013122 |
| 91 | atrioventricular valve morphogenesis (GO:0003181) | 2.60468023 |
| 92 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.60212335 |
| 93 | dendritic cell migration (GO:0036336) | 2.58927854 |
| 94 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.58738348 |
| 95 | opioid receptor signaling pathway (GO:0038003) | 2.58361070 |
| 96 | tRNA modification (GO:0006400) | 2.57921917 |
| 97 | protein heterotetramerization (GO:0051290) | 2.57917181 |
| 98 | amyloid precursor protein catabolic process (GO:0042987) | 2.57093728 |
| 99 | negative regulation of cell killing (GO:0031342) | 2.57088003 |
| 100 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57088003 |
| 101 | positive regulation of nuclease activity (GO:0032075) | 2.57060973 |
| 102 | viral mRNA export from host cell nucleus (GO:0046784) | 2.56776459 |
| 103 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.56036674 |
| 104 | negative regulation of telomere maintenance (GO:0032205) | 2.55972289 |
| 105 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.55464378 |
| 106 | maternal placenta development (GO:0001893) | 2.55028046 |
| 107 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.54515958 |
| 108 | telomere maintenance via recombination (GO:0000722) | 2.54127624 |
| 109 | rRNA modification (GO:0000154) | 2.53226490 |
| 110 | respiratory burst (GO:0045730) | 2.53100629 |
| 111 | response to laminar fluid shear stress (GO:0034616) | 2.52731001 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51832234 |
| 113 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.51405698 |
| 114 | regulation of extracellular matrix disassembly (GO:0010715) | 2.51247697 |
| 115 | T cell migration (GO:0072678) | 2.50463304 |
| 116 | proline metabolic process (GO:0006560) | 2.50312553 |
| 117 | base-excision repair, AP site formation (GO:0006285) | 2.50201163 |
| 118 | DNA damage response, detection of DNA damage (GO:0042769) | 2.50196555 |
| 119 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.49310576 |
| 120 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.49310576 |
| 121 | modulation by symbiont of host immune response (GO:0052553) | 2.49310576 |
| 122 | positive regulation by symbiont of host defense response (GO:0052509) | 2.49310576 |
| 123 | modulation by symbiont of host defense response (GO:0052031) | 2.49310576 |
| 124 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.49310576 |
| 125 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.49138370 |
| 126 | cell-substrate junction assembly (GO:0007044) | 2.48667977 |
| 127 | termination of RNA polymerase I transcription (GO:0006363) | 2.48465512 |
| 128 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.48250459 |
| 129 | apoptotic cell clearance (GO:0043277) | 2.48008604 |
| 130 | cellular copper ion homeostasis (GO:0006878) | 2.47566123 |
| 131 | virion assembly (GO:0019068) | 2.45991007 |
| 132 | histamine secretion (GO:0001821) | 2.45770507 |
| 133 | adherens junction assembly (GO:0034333) | 2.45745697 |
| 134 | ribosomal small subunit biogenesis (GO:0042274) | 2.44926247 |
| 135 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.44910519 |
| 136 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.44910519 |
| 137 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.44910519 |
| 138 | activation of MAPKKK activity (GO:0000185) | 2.43826978 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.43203797 |
| 140 | hemidesmosome assembly (GO:0031581) | 2.42963204 |
| 141 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.41885413 |
| 142 | amino sugar catabolic process (GO:0046348) | 2.41521409 |
| 143 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.41254034 |
| 144 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.41112174 |
| 145 | type B pancreatic cell proliferation (GO:0044342) | 2.40267117 |
| 146 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.40184730 |
| 147 | DNA strand renaturation (GO:0000733) | 2.40120234 |
| 148 | transcription from RNA polymerase I promoter (GO:0006360) | 2.39650399 |
| 149 | modulation by virus of host morphology or physiology (GO:0019048) | 2.39061834 |
| 150 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.38999311 |
| 151 | negative regulation of B cell mediated immunity (GO:0002713) | 2.38999311 |
| 152 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.38881291 |
| 153 | regulation of superoxide anion generation (GO:0032928) | 2.38855113 |
| 154 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.38315778 |
| 155 | maturation of 5.8S rRNA (GO:0000460) | 2.38299721 |
| 156 | peptidyl-histidine modification (GO:0018202) | 2.38273988 |
| 157 | RNA methylation (GO:0001510) | 2.38239843 |
| 158 | regulation of necrotic cell death (GO:0010939) | 2.36983152 |
| 159 | microtubule depolymerization (GO:0007019) | 2.36867273 |
| 160 | maintenance of protein localization in organelle (GO:0072595) | 2.34885274 |
| 161 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.33593780 |
| 162 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.33593780 |
| 163 | endodermal cell differentiation (GO:0035987) | 2.33468325 |
| 164 | sphingolipid catabolic process (GO:0030149) | 2.33186652 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.32505876 |
| 166 | DNA-dependent DNA replication (GO:0006261) | 2.32335556 |
| 167 | regulation of activation of Janus kinase activity (GO:0010533) | 2.32198267 |
| 168 | tRNA processing (GO:0008033) | 2.31950174 |
| 169 | embryo implantation (GO:0007566) | 2.31521078 |
| 170 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.31485997 |
| 171 | focal adhesion assembly (GO:0048041) | 2.31174928 |
| 172 | cell-substrate adherens junction assembly (GO:0007045) | 2.31174928 |
| 173 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.31151911 |
| 174 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.30187058 |
| 175 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.29869797 |
| 176 | replication fork processing (GO:0031297) | 2.29843827 |
| 177 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.29693812 |
| 178 | kinetochore assembly (GO:0051382) | 2.29250471 |
| 179 | retrograde transport, endosome to Golgi (GO:0042147) | 2.28474370 |
| 180 | adhesion of symbiont to host (GO:0044406) | 2.23421360 |
| 181 | regulation of mitochondrial membrane potential (GO:0051881) | 2.22219607 |
| 182 | low-density lipoprotein particle clearance (GO:0034383) | 2.21809764 |
| 183 | regulation of nuclease activity (GO:0032069) | 2.21108356 |
| 184 | cellular response to unfolded protein (GO:0034620) | 2.19586853 |
| 185 | galactose catabolic process (GO:0019388) | 2.18681209 |
| 186 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.18652923 |
| 187 | lipopolysaccharide metabolic process (GO:0008653) | 2.17817272 |
| 188 | positive regulation of extracellular matrix organization (GO:1903055) | 2.17328678 |
| 189 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.17258080 |
| 190 | angiogenesis involved in wound healing (GO:0060055) | 2.16878955 |
| 191 | heme biosynthetic process (GO:0006783) | 2.16254832 |
| 192 | ER-nucleus signaling pathway (GO:0006984) | 2.15823411 |
| 193 | regulation of cholesterol esterification (GO:0010872) | 2.15322397 |
| 194 | negative regulation of viral release from host cell (GO:1902187) | 2.15040022 |
| 195 | hypotonic response (GO:0006971) | 2.14127752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.64272412 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.61745933 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.53317239 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19624115 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.14411205 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.09687802 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.06701412 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.99960668 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.89082001 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.84480050 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64936419 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.63594834 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.57714091 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.55878013 |
| 15 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.55841403 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.55122136 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52645991 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.47928862 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46680729 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.43071235 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.35597436 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34452661 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33070589 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31140719 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31065385 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23400286 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18161487 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15132178 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.13247295 |
| 30 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.12097570 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.10026403 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06626656 |
| 33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.03042184 |
| 34 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00058157 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98127996 |
| 36 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.97775450 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.97753584 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.97355923 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.94275852 |
| 40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.92724243 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.91649962 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83531877 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80730475 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80646386 |
| 45 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.80045629 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.77912589 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77248771 |
| 48 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.76883257 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76677870 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.74135691 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73035589 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.72738344 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.70684140 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.70014283 |
| 55 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.67273547 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61587462 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59457981 |
| 58 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.58124041 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.53798186 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51599877 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.51117735 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50148242 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49371164 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48339495 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48143856 |
| 66 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.47267739 |
| 67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47218585 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.46923801 |
| 69 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46764255 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46506236 |
| 71 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46267771 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44535422 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43364569 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42035067 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41858425 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40923630 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40795063 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40276576 |
| 79 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40054323 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39611041 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38835065 |
| 82 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38161508 |
| 83 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.37588172 |
| 84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35355909 |
| 85 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34267260 |
| 86 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34062101 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.33811945 |
| 88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31730037 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31492700 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31235543 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31059891 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30905133 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30830871 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30695736 |
| 95 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.30536634 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29775766 |
| 97 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29642824 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29412914 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28268199 |
| 100 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.28016290 |
| 101 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27920244 |
| 102 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.27053938 |
| 103 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27024955 |
| 104 | MAF_26560356_Chip-Seq_TH2_Human | 1.25884975 |
| 105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25580229 |
| 106 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23780226 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23330090 |
| 108 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.23148305 |
| 109 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22255163 |
| 110 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21109996 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21100599 |
| 112 | MAF_26560356_Chip-Seq_TH1_Human | 1.20645155 |
| 113 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18977127 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18738007 |
| 115 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18735521 |
| 116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18507575 |
| 117 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18084981 |
| 118 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17907277 |
| 119 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17735282 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17541591 |
| 121 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17482169 |
| 122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17284548 |
| 123 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.17262358 |
| 124 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17033101 |
| 125 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16724747 |
| 126 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16647609 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15236114 |
| 128 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15151906 |
| 129 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.14874219 |
| 130 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14457224 |
| 131 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.13616017 |
| 132 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13180214 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12483075 |
| 134 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12375476 |
| 135 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12280467 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12174079 |
| 137 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.12053714 |
| 138 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11668393 |
| 139 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11440528 |
| 140 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11119520 |
| 141 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.11071118 |
| 142 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10390634 |
| 143 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10209967 |
| 144 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10139263 |
| 145 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.10019984 |
| 146 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.09882929 |
| 147 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09868799 |
| 148 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09795434 |
| 149 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09426959 |
| 150 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.09398786 |
| 151 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.08916634 |
| 152 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08858208 |
| 153 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08558132 |
| 154 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08072416 |
| 155 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08046812 |
| 156 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07242628 |
| 157 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06636806 |
| 158 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.05857222 |
| 159 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.05044212 |
| 160 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04750167 |
| 161 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02549140 |
| 162 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02428912 |
| 163 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.02401338 |
| 164 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.02265561 |
| 165 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02137821 |
| 166 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01867067 |
| 167 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.01232192 |
| 168 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01038175 |
| 169 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00620985 |
| 170 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99795738 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99602819 |
| 172 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99158601 |
| 173 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.99068223 |
| 174 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98854049 |
| 175 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98143479 |
| 176 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97149784 |
| 177 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96468386 |
| 178 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94963901 |
| 179 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94843836 |
| 180 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.94371711 |
| 181 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94316638 |
| 182 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94125725 |
| 183 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.93087024 |
| 184 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91631091 |
| 185 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91257474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.95232967 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.90245361 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.76600646 |
| 4 | MP0005451_abnormal_body_composition | 3.65663402 |
| 5 | MP0009840_abnormal_foam_cell | 3.24801168 |
| 6 | MP0001188_hyperpigmentation | 3.07241925 |
| 7 | MP0000015_abnormal_ear_pigmentation | 2.98388303 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.83430827 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.74297798 |
| 10 | MP0005671_abnormal_response_to | 2.71733420 |
| 11 | MP0009785_altered_susceptibility_to | 2.30672388 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.28644802 |
| 13 | MP0004858_abnormal_nervous_system | 2.25420440 |
| 14 | MP0005171_absent_coat_pigmentation | 2.23603435 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.21174308 |
| 16 | MP0004272_abnormal_basement_membrane | 2.19601945 |
| 17 | MP0001849_ear_inflammation | 2.17865656 |
| 18 | MP0003941_abnormal_skin_development | 2.17527446 |
| 19 | MP0005174_abnormal_tail_pigmentation | 2.16990234 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 2.14955373 |
| 21 | MP0008058_abnormal_DNA_repair | 2.12441890 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.10392582 |
| 23 | MP0001790_abnormal_immune_system | 2.07906188 |
| 24 | MP0005387_immune_system_phenotype | 2.07906188 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.07032665 |
| 26 | MP0006292_abnormal_olfactory_placode | 2.05709826 |
| 27 | MP0002419_abnormal_innate_immunity | 2.03868542 |
| 28 | MP0002132_abnormal_respiratory_system | 1.99362539 |
| 29 | MP0000566_synostosis | 1.88341716 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.87756311 |
| 31 | MP0003436_decreased_susceptibility_to | 1.87181310 |
| 32 | MP0004381_abnormal_hair_follicle | 1.86470400 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.85680872 |
| 34 | MP0001819_abnormal_immune_cell | 1.84804832 |
| 35 | MP0005409_darkened_coat_color | 1.79515404 |
| 36 | MP0005025_abnormal_response_to | 1.77258340 |
| 37 | MP0002723_abnormal_immune_serum | 1.75862463 |
| 38 | MP0000858_altered_metastatic_potential | 1.75080077 |
| 39 | MP0001800_abnormal_humoral_immune | 1.74831781 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.74318653 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.72369210 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.71629260 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.66482868 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.66057127 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.63592513 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.61870907 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.61451486 |
| 48 | MP0003786_premature_aging | 1.60587577 |
| 49 | MP0010030_abnormal_orbit_morphology | 1.59425533 |
| 50 | MP0003724_increased_susceptibility_to | 1.59293176 |
| 51 | MP0004510_myositis | 1.58959582 |
| 52 | MP0001853_heart_inflammation | 1.56595198 |
| 53 | MP0004233_abnormal_muscle_weight | 1.54318773 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.51357719 |
| 55 | MP0002405_respiratory_system_inflammati | 1.49732411 |
| 56 | MP0009278_abnormal_bone_marrow | 1.48388994 |
| 57 | MP0005670_abnormal_white_adipose | 1.46916283 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.46440535 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.45581235 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.45172206 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.45000169 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.43409243 |
| 63 | MP0003091_abnormal_cell_migration | 1.42617412 |
| 64 | MP0005023_abnormal_wound_healing | 1.42535191 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.40939770 |
| 66 | MP0008007_abnormal_cellular_replicative | 1.40697066 |
| 67 | MP0006082_CNS_inflammation | 1.38702040 |
| 68 | MP0002398_abnormal_bone_marrow | 1.38358897 |
| 69 | MP0003303_peritoneal_inflammation | 1.36809659 |
| 70 | MP0000751_myopathy | 1.35239937 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.34115925 |
| 72 | MP0000716_abnormal_immune_system | 1.33536891 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.32928744 |
| 74 | MP0003448_altered_tumor_morphology | 1.32591526 |
| 75 | MP0004947_skin_inflammation | 1.31540479 |
| 76 | MP0002933_joint_inflammation | 1.31405249 |
| 77 | MP0003787_abnormal_imprinting | 1.31378186 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 1.29972854 |
| 79 | MP0005501_abnormal_skin_physiology | 1.29965932 |
| 80 | MP0001958_emphysema | 1.29895424 |
| 81 | MP0001542_abnormal_bone_strength | 1.26467632 |
| 82 | MP0009764_decreased_sensitivity_to | 1.25985928 |
| 83 | MP0000750_abnormal_muscle_regeneration | 1.25491901 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.25454820 |
| 85 | MP0000689_abnormal_spleen_morphology | 1.24699329 |
| 86 | MP0002095_abnormal_skin_pigmentation | 1.24513218 |
| 87 | MP0002060_abnormal_skin_morphology | 1.22660582 |
| 88 | MP0008995_early_reproductive_senescence | 1.22358650 |
| 89 | MP0005375_adipose_tissue_phenotype | 1.22012751 |
| 90 | MP0002638_abnormal_pupillary_reflex | 1.21732511 |
| 91 | MP0002163_abnormal_gland_morphology | 1.21502902 |
| 92 | MP0005083_abnormal_biliary_tract | 1.20880562 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 1.20061164 |
| 94 | MP0010094_abnormal_chromosome_stability | 1.19884417 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 1.19807033 |
| 96 | MP0002722_abnormal_immune_system | 1.17014008 |
| 97 | MP0003136_yellow_coat_color | 1.15414378 |
| 98 | MP0001186_pigmentation_phenotype | 1.14940842 |
| 99 | MP0005666_abnormal_adipose_tissue | 1.12498364 |
| 100 | MP0000343_altered_response_to | 1.11954477 |
| 101 | MP0002102_abnormal_ear_morphology | 1.11866389 |
| 102 | MP0000685_abnormal_immune_system | 1.11766155 |
| 103 | MP0003186_abnormal_redox_activity | 1.11721822 |
| 104 | MP0005503_abnormal_tendon_morphology | 1.11510850 |
| 105 | MP0002160_abnormal_reproductive_system | 1.11079151 |
| 106 | MP0000703_abnormal_thymus_morphology | 1.10785357 |
| 107 | MP0008004_abnormal_stomach_pH | 1.10259505 |
| 108 | MP0002876_abnormal_thyroid_physiology | 1.09240954 |
| 109 | MP0005275_abnormal_skin_tensile | 1.08560476 |
| 110 | MP0000681_abnormal_thyroid_gland | 1.07257308 |
| 111 | MP0002429_abnormal_blood_cell | 1.05422597 |
| 112 | MP0003300_gastrointestinal_ulcer | 1.05292483 |
| 113 | MP0000733_abnormal_muscle_development | 1.05227927 |
| 114 | MP0002396_abnormal_hematopoietic_system | 1.04925421 |
| 115 | MP0001533_abnormal_skeleton_physiology | 1.04916553 |
| 116 | MP0000767_abnormal_smooth_muscle | 1.04767840 |
| 117 | MP0008260_abnormal_autophagy | 1.01522198 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 1.01288490 |
| 119 | MP0001545_abnormal_hematopoietic_system | 1.01288490 |
| 120 | MP0001845_abnormal_inflammatory_respons | 1.01154494 |
| 121 | MP0003075_altered_response_to | 1.00805358 |
| 122 | MP0000604_amyloidosis | 1.00213511 |
| 123 | MP0003329_amyloid_beta_deposits | 0.99666956 |
| 124 | MP0003828_pulmonary_edema | 0.99164464 |
| 125 | MP0003880_abnormal_central_pattern | 0.98460040 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.97979667 |
| 127 | MP0001243_abnormal_dermal_layer | 0.97848269 |
| 128 | MP0003315_abnormal_perineum_morphology | 0.97344937 |
| 129 | MP0005330_cardiomyopathy | 0.97333557 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.97063244 |
| 131 | MP0005390_skeleton_phenotype | 0.96527857 |
| 132 | MP0002796_impaired_skin_barrier | 0.96225435 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.94985814 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.94865128 |
| 135 | MP0009697_abnormal_copulation | 0.94364649 |
| 136 | MP0005310_abnormal_salivary_gland | 0.94265427 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.94115508 |
| 138 | MP0000049_abnormal_middle_ear | 0.92149539 |
| 139 | MP0005621_abnormal_cell_physiology | 0.91647800 |
| 140 | MP0002089_abnormal_postnatal_growth/wei | 0.91329125 |
| 141 | MP0008057_abnormal_DNA_replication | 0.90569216 |
| 142 | MP0002998_abnormal_bone_remodeling | 0.90041815 |
| 143 | MP0001529_abnormal_vocalization | 0.89836820 |
| 144 | MP0005389_reproductive_system_phenotype | 0.89075764 |
| 145 | MP0000490_abnormal_crypts_of | 0.88597644 |
| 146 | MP0006054_spinal_hemorrhage | 0.87939199 |
| 147 | MP0003279_aneurysm | 0.87316567 |
| 148 | MP0003172_abnormal_lysosome_physiology | 0.86291004 |
| 149 | MP0009931_abnormal_skin_appearance | 0.85945750 |
| 150 | MP0001919_abnormal_reproductive_system | 0.85805348 |
| 151 | MP0000613_abnormal_salivary_gland | 0.85573382 |
| 152 | MP0010368_abnormal_lymphatic_system | 0.85024124 |
| 153 | MP0004142_abnormal_muscle_tone | 0.84771697 |
| 154 | MP0002075_abnormal_coat/hair_pigmentati | 0.84352257 |
| 155 | MP0001915_intracranial_hemorrhage | 0.84037067 |
| 156 | MP0001216_abnormal_epidermal_layer | 0.83684572 |
| 157 | MP0002254_reproductive_system_inflammat | 0.82449857 |
| 158 | MP0000759_abnormal_skeletal_muscle | 0.82067846 |
| 159 | MP0000678_abnormal_parathyroid_gland | 0.81944988 |
| 160 | MP0000358_abnormal_cell_content/ | 0.81527359 |
| 161 | MP0001119_abnormal_female_reproductive | 0.80655937 |
| 162 | MP0004133_heterotaxia | 0.80631055 |
| 163 | MP0003718_maternal_effect | 0.80232502 |
| 164 | MP0005508_abnormal_skeleton_morphology | 0.79518741 |
| 165 | MP0002295_abnormal_pulmonary_circulatio | 0.77345406 |
| 166 | MP0005165_increased_susceptibility_to | 0.77261673 |
| 167 | MP0005360_urolithiasis | 0.76716787 |
| 168 | MP0001730_embryonic_growth_arrest | 0.75499051 |
| 169 | MP0001661_extended_life_span | 0.75259648 |
| 170 | MP0005384_cellular_phenotype | 0.74692423 |
| 171 | MP0000747_muscle_weakness | 0.74412978 |
| 172 | MP0008469_abnormal_protein_level | 0.74242402 |
| 173 | MP0000467_abnormal_esophagus_morphology | 0.72702216 |
| 174 | MP0009053_abnormal_anal_canal | 0.72684846 |
| 175 | MP0000537_abnormal_urethra_morphology | 0.71950320 |
| 176 | MP0002249_abnormal_larynx_morphology | 0.68625385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.10681909 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.70470377 |
| 3 | Chromsome breakage (HP:0040012) | 4.43791769 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.07141047 |
| 5 | Vertebral compression fractures (HP:0002953) | 4.01955258 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.52471020 |
| 7 | Abnormality of the renal collecting system (HP:0004742) | 3.47963628 |
| 8 | Duplicated collecting system (HP:0000081) | 3.40211211 |
| 9 | Type 2 muscle fiber atrophy (HP:0003554) | 3.01817098 |
| 10 | Dysostosis multiplex (HP:0000943) | 2.98926577 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 2.98040999 |
| 12 | Optic neuritis (HP:0100653) | 2.98040999 |
| 13 | Achilles tendon contracture (HP:0001771) | 2.97231049 |
| 14 | Cervical subluxation (HP:0003308) | 2.95942325 |
| 15 | Meckel diverticulum (HP:0002245) | 2.83438743 |
| 16 | Abnormality of the preputium (HP:0100587) | 2.77675109 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.76837109 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76819403 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76819403 |
| 20 | Abnormality of the ileum (HP:0001549) | 2.73775884 |
| 21 | Congenital stationary night blindness (HP:0007642) | 2.72930565 |
| 22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.72548181 |
| 23 | Severe combined immunodeficiency (HP:0004430) | 2.71928325 |
| 24 | Short nail (HP:0001799) | 2.70054280 |
| 25 | Abnormality of the Achilles tendon (HP:0005109) | 2.68785422 |
| 26 | Ragged-red muscle fibers (HP:0003200) | 2.68728596 |
| 27 | Distal upper limb amyotrophy (HP:0007149) | 2.68162194 |
| 28 | Upper limb amyotrophy (HP:0009129) | 2.68162194 |
| 29 | Distal lower limb muscle weakness (HP:0009053) | 2.66545203 |
| 30 | Ankle contracture (HP:0006466) | 2.66110307 |
| 31 | Clubbing of toes (HP:0100760) | 2.64640568 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62657763 |
| 33 | Obstructive lung disease (HP:0006536) | 2.62657763 |
| 34 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.62239966 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.61870983 |
| 36 | Axonal loss (HP:0003447) | 2.59781431 |
| 37 | Fragile skin (HP:0001030) | 2.58450422 |
| 38 | Abnormal hair whorl (HP:0010721) | 2.53884395 |
| 39 | Hyperacusis (HP:0010780) | 2.53070774 |
| 40 | Type I transferrin isoform profile (HP:0003642) | 2.50326816 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.48284545 |
| 42 | Stomatitis (HP:0010280) | 2.48050224 |
| 43 | * Atrophic scars (HP:0001075) | 2.47610919 |
| 44 | Muscle fiber atrophy (HP:0100295) | 2.45464711 |
| 45 | Meningitis (HP:0001287) | 2.45218529 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.45075757 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.43828782 |
| 48 | Microvesicular hepatic steatosis (HP:0001414) | 2.42186434 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.41869873 |
| 50 | Increased IgM level (HP:0003496) | 2.41213258 |
| 51 | Blue sclerae (HP:0000592) | 2.40968837 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.40566580 |
| 53 | True hermaphroditism (HP:0010459) | 2.40560576 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.37627236 |
| 55 | Abnormality of dentin (HP:0010299) | 2.36878682 |
| 56 | Prostate neoplasm (HP:0100787) | 2.36772614 |
| 57 | Joint stiffness (HP:0001387) | 2.35124888 |
| 58 | Elbow flexion contracture (HP:0002987) | 2.33866708 |
| 59 | Eczematoid dermatitis (HP:0000976) | 2.32726187 |
| 60 | Biconcave vertebral bodies (HP:0004586) | 2.32275921 |
| 61 | Abnormality of DNA repair (HP:0003254) | 2.31767657 |
| 62 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31387134 |
| 63 | Premature skin wrinkling (HP:0100678) | 2.31219762 |
| 64 | Broad distal phalanx of finger (HP:0009836) | 2.31177518 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30445731 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30445731 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30445731 |
| 68 | Orchitis (HP:0100796) | 2.30004330 |
| 69 | Myositis (HP:0100614) | 2.29908539 |
| 70 | Granulocytopenia (HP:0001913) | 2.29258507 |
| 71 | Reticulocytopenia (HP:0001896) | 2.28753244 |
| 72 | Recurrent fungal infections (HP:0002841) | 2.28677169 |
| 73 | Encephalitis (HP:0002383) | 2.27435116 |
| 74 | Abnormality of macrophages (HP:0004311) | 2.27004013 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26310442 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.26310442 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.25248953 |
| 78 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.23383819 |
| 79 | Ulnar bowing (HP:0003031) | 2.22348461 |
| 80 | Hypertensive crisis (HP:0100735) | 2.21656254 |
| 81 | IgM deficiency (HP:0002850) | 2.20538714 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.20452537 |
| 83 | Stridor (HP:0010307) | 2.19685008 |
| 84 | Spinal rigidity (HP:0003306) | 2.19463201 |
| 85 | Cheilitis (HP:0100825) | 2.16472739 |
| 86 | Thyroiditis (HP:0100646) | 2.15605572 |
| 87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.15314747 |
| 88 | Upper limb muscle weakness (HP:0003484) | 2.14991681 |
| 89 | Bone marrow hypocellularity (HP:0005528) | 2.14945079 |
| 90 | Abnormality of chromosome stability (HP:0003220) | 2.14599540 |
| 91 | Hand muscle atrophy (HP:0009130) | 2.11739126 |
| 92 | Flattened epiphyses (HP:0003071) | 2.11663393 |
| 93 | Generalized amyotrophy (HP:0003700) | 2.11306362 |
| 94 | J-shaped sella turcica (HP:0002680) | 2.11152445 |
| 95 | Increased serum ferritin (HP:0003281) | 2.10972998 |
| 96 | Genu recurvatum (HP:0002816) | 2.08993934 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.07903380 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.07462057 |
| 99 | Birth length less than 3rd percentile (HP:0003561) | 2.07216759 |
| 100 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07125378 |
| 101 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07125378 |
| 102 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07125378 |
| 103 | Increased connective tissue (HP:0009025) | 2.06516473 |
| 104 | Loss of speech (HP:0002371) | 2.06259229 |
| 105 | Bladder diverticulum (HP:0000015) | 2.05709788 |
| 106 | Chronic diarrhea (HP:0002028) | 2.04744299 |
| 107 | Progressive external ophthalmoplegia (HP:0000590) | 2.04423869 |
| 108 | Entropion (HP:0000621) | 2.04041164 |
| 109 | Recurrent pneumonia (HP:0006532) | 2.03537732 |
| 110 | Combined immunodeficiency (HP:0005387) | 2.02867773 |
| 111 | Abnormality of T cell number (HP:0011839) | 2.01739075 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01284405 |
| 113 | Thin bony cortex (HP:0002753) | 2.00474159 |
| 114 | Fatigue (HP:0012378) | 2.00170770 |
| 115 | Trismus (HP:0000211) | 1.98122898 |
| 116 | Pancreatic cysts (HP:0001737) | 1.98120802 |
| 117 | Myocardial infarction (HP:0001658) | 1.96997705 |
| 118 | Recurrent skin infections (HP:0001581) | 1.96082862 |
| 119 | Eosinophilia (HP:0001880) | 1.95871281 |
| 120 | Mitral regurgitation (HP:0001653) | 1.94786428 |
| 121 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94093080 |
| 122 | Abnormality of the thoracic spine (HP:0100711) | 1.93854783 |
| 123 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93234843 |
| 124 | Rough bone trabeculation (HP:0100670) | 1.92294628 |
| 125 | Septo-optic dysplasia (HP:0100842) | 1.92123015 |
| 126 | IgG deficiency (HP:0004315) | 1.91706500 |
| 127 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91499431 |
| 128 | Nuclear cataract (HP:0100018) | 1.91140639 |
| 129 | Long palpebral fissure (HP:0000637) | 1.90940778 |
| 130 | Cellulitis (HP:0100658) | 1.90803957 |
| 131 | Disproportionate tall stature (HP:0001519) | 1.90217992 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 1.89364495 |
| 133 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89000948 |
| 134 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88899331 |
| 135 | T lymphocytopenia (HP:0005403) | 1.88493510 |
| 136 | Upper motor neuron abnormality (HP:0002127) | 1.88378647 |
| 137 | Wormian bones (HP:0002645) | 1.87702004 |
| 138 | Keratoconjunctivitis sicca (HP:0001097) | 1.87540303 |
| 139 | Abnormality of the acetabulum (HP:0003170) | 1.86606680 |
| 140 | Testicular atrophy (HP:0000029) | 1.86335411 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.85138727 |
| 142 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.82884735 |
| 143 | Natal tooth (HP:0000695) | 1.82234774 |
| 144 | Broad face (HP:0000283) | 1.81354885 |
| 145 | Pancreatic fibrosis (HP:0100732) | 1.81196639 |
| 146 | Dilatation of the ascending aorta (HP:0005111) | 1.80113036 |
| 147 | Flat capital femoral epiphysis (HP:0003370) | 1.80000536 |
| 148 | Hypothermia (HP:0002045) | 1.79985721 |
| 149 | Purpura (HP:0000979) | 1.79685521 |
| 150 | Ectopic kidney (HP:0000086) | 1.79229141 |
| 151 | Prolonged neonatal jaundice (HP:0006579) | 1.78284564 |
| 152 | Leukocytosis (HP:0001974) | 1.77695778 |
| 153 | Petechiae (HP:0000967) | 1.76897491 |
| 154 | Glomerulopathy (HP:0100820) | 1.75514861 |
| 155 | Systemic lupus erythematosus (HP:0002725) | 1.75490636 |
| 156 | Flat acetabular roof (HP:0003180) | 1.75206763 |
| 157 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74413541 |
| 158 | Difficulty climbing stairs (HP:0003551) | 1.74353460 |
| 159 | Recurrent lower respiratory tract infections (HP:0002783) | 1.74094135 |
| 160 | Hepatosplenomegaly (HP:0001433) | 1.73054590 |
| 161 | Triphalangeal thumb (HP:0001199) | 1.73030552 |
| 162 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.72820567 |
| 163 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.72820567 |
| 164 | Abnormal protein glycosylation (HP:0012346) | 1.72820567 |
| 165 | Abnormal glycosylation (HP:0012345) | 1.72820567 |
| 166 | Deep venous thrombosis (HP:0002625) | 1.72625817 |
| 167 | Congenital glaucoma (HP:0001087) | 1.72492007 |
| 168 | Reduced antithrombin III activity (HP:0001976) | 1.72364640 |
| 169 | Abnormality of incisor morphology (HP:0011063) | 1.72288832 |
| 170 | Preaxial hand polydactyly (HP:0001177) | 1.71853513 |
| 171 | Progressive muscle weakness (HP:0003323) | 1.71172741 |
| 172 | Neoplasm of the adrenal cortex (HP:0100641) | 1.70700265 |
| 173 | Atelectasis (HP:0100750) | 1.69857586 |
| 174 | Aortic dissection (HP:0002647) | 1.69690065 |
| 175 | Abnormality of carpal bone ossification (HP:0006257) | 1.69335974 |
| 176 | Polygenic inheritance (HP:0010982) | 1.69247087 |
| 177 | Abnormality of the carotid arteries (HP:0005344) | 1.68746751 |
| 178 | Keratoconjunctivitis (HP:0001096) | 1.67285237 |
| 179 | Myopathic facies (HP:0002058) | 1.66456570 |
| 180 | Abnormality of T cells (HP:0002843) | 1.66279587 |
| 181 | Hypoplasia of the fovea (HP:0007750) | 1.65705329 |
| 182 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.65705329 |
| 183 | Pancytopenia (HP:0001876) | 1.65647968 |
| 184 | Amyloidosis (HP:0011034) | 1.65502651 |
| 185 | Recurrent viral infections (HP:0004429) | 1.65347339 |
| 186 | Pulmonary infiltrates (HP:0002113) | 1.65171269 |
| 187 | Optic nerve coloboma (HP:0000588) | 1.65083728 |
| 188 | * Joint laxity (HP:0001388) | 1.64585070 |
| 189 | Venous abnormality (HP:0002624) | 1.64077156 |
| 190 | Abnormality of the tricuspid valve (HP:0001702) | 1.63958303 |
| 191 | Bulbar palsy (HP:0001283) | 1.63168484 |
| 192 | Breast hypoplasia (HP:0003187) | 1.63008176 |
| 193 | Abnormality of the umbilical cord (HP:0010881) | 1.62504375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.20727003 |
| 2 | TRIB3 | 3.98680857 |
| 3 | IRAK4 | 3.70504352 |
| 4 | ZAK | 3.33624252 |
| 5 | STK16 | 3.20499435 |
| 6 | TXK | 3.08525136 |
| 7 | ERN1 | 3.02512598 |
| 8 | MAP3K14 | 2.71924609 |
| 9 | CASK | 2.53110499 |
| 10 | SIK3 | 2.49172354 |
| 11 | SIK1 | 2.47224936 |
| 12 | SMG1 | 2.43106781 |
| 13 | PLK4 | 2.38505380 |
| 14 | MAP2K3 | 2.18822913 |
| 15 | BUB1 | 2.18297131 |
| 16 | ARAF | 1.96888040 |
| 17 | MARK1 | 1.83490002 |
| 18 | BLK | 1.81319309 |
| 19 | IRAK1 | 1.72932330 |
| 20 | IRAK2 | 1.65045046 |
| 21 | TTN | 1.64549868 |
| 22 | ADRBK2 | 1.64287379 |
| 23 | ICK | 1.60778575 |
| 24 | TAOK2 | 1.60690577 |
| 25 | BCKDK | 1.57009296 |
| 26 | YES1 | 1.52627078 |
| 27 | SRPK1 | 1.52601650 |
| 28 | PKN2 | 1.51218687 |
| 29 | RIPK1 | 1.51161888 |
| 30 | GRK1 | 1.50571559 |
| 31 | EPHB1 | 1.50465091 |
| 32 | EIF2AK2 | 1.49164871 |
| 33 | PIM2 | 1.48360537 |
| 34 | NME2 | 1.46800700 |
| 35 | PAK4 | 1.44710054 |
| 36 | TNIK | 1.42866332 |
| 37 | CLK1 | 1.39714416 |
| 38 | BMPR1B | 1.39520877 |
| 39 | ABL2 | 1.36974940 |
| 40 | PRPF4B | 1.35321037 |
| 41 | MAP3K3 | 1.34995121 |
| 42 | TEC | 1.32714854 |
| 43 | LIMK1 | 1.32559579 |
| 44 | IKBKE | 1.28997231 |
| 45 | MKNK2 | 1.25587378 |
| 46 | PRKD2 | 1.23010934 |
| 47 | PDGFRA | 1.22008365 |
| 48 | DDR2 | 1.20246695 |
| 49 | LMTK2 | 1.18041780 |
| 50 | VRK1 | 1.17641775 |
| 51 | MAP4K1 | 1.14685678 |
| 52 | IKBKB | 1.14073975 |
| 53 | EPHB2 | 1.10915121 |
| 54 | TLK1 | 1.08724772 |
| 55 | PTK2 | 1.06260493 |
| 56 | BMPR2 | 1.05311254 |
| 57 | MST1R | 1.04532254 |
| 58 | GRK7 | 1.02546413 |
| 59 | EIF2AK3 | 1.01176933 |
| 60 | MKNK1 | 1.00874807 |
| 61 | VRK2 | 1.00593672 |
| 62 | ERBB3 | 1.00110402 |
| 63 | DYRK2 | 0.99964741 |
| 64 | NLK | 0.98497687 |
| 65 | TAOK1 | 0.98231791 |
| 66 | AKT3 | 0.96380237 |
| 67 | NEK6 | 0.96352408 |
| 68 | MAP3K1 | 0.96095779 |
| 69 | INSRR | 0.93956817 |
| 70 | MAP2K7 | 0.90255547 |
| 71 | KDR | 0.89830288 |
| 72 | BCR | 0.89020393 |
| 73 | RPS6KA2 | 0.88675176 |
| 74 | PBK | 0.88259578 |
| 75 | EEF2K | 0.87231161 |
| 76 | MARK2 | 0.84204456 |
| 77 | MAPK13 | 0.78873207 |
| 78 | JAK3 | 0.78824782 |
| 79 | PLK3 | 0.77663429 |
| 80 | SYK | 0.77540242 |
| 81 | LRRK2 | 0.76852747 |
| 82 | FGFR4 | 0.76229708 |
| 83 | LYN | 0.75381129 |
| 84 | PIM1 | 0.75355282 |
| 85 | EPHA2 | 0.74853143 |
| 86 | PDPK1 | 0.74248268 |
| 87 | KIT | 0.74199993 |
| 88 | MAPK11 | 0.74194012 |
| 89 | BRD4 | 0.74056464 |
| 90 | PTK6 | 0.73211024 |
| 91 | TYK2 | 0.73174247 |
| 92 | MTOR | 0.73006916 |
| 93 | TGFBR2 | 0.72926461 |
| 94 | TNK2 | 0.72603492 |
| 95 | ITK | 0.72262109 |
| 96 | NTRK1 | 0.72085509 |
| 97 | ATR | 0.71689551 |
| 98 | TBK1 | 0.71465875 |
| 99 | MAP3K6 | 0.70452452 |
| 100 | ILK | 0.69541045 |
| 101 | ZAP70 | 0.69180423 |
| 102 | PRKCI | 0.68550589 |
| 103 | CDK3 | 0.68395515 |
| 104 | BMX | 0.68071288 |
| 105 | MAP3K8 | 0.67516142 |
| 106 | PLK2 | 0.65275888 |
| 107 | MAP2K2 | 0.64862233 |
| 108 | MAP3K12 | 0.63019030 |
| 109 | PASK | 0.62415076 |
| 110 | BTK | 0.61981246 |
| 111 | CDK12 | 0.61648195 |
| 112 | CDK8 | 0.60427394 |
| 113 | EIF2AK1 | 0.59673743 |
| 114 | MAPKAPK3 | 0.59632571 |
| 115 | DAPK3 | 0.59371145 |
| 116 | PRKD3 | 0.59117087 |
| 117 | STK38 | 0.58866169 |
| 118 | MOS | 0.58826406 |
| 119 | LCK | 0.58739364 |
| 120 | CDC42BPA | 0.58648367 |
| 121 | RPS6KL1 | 0.58491634 |
| 122 | RPS6KC1 | 0.58491634 |
| 123 | MARK3 | 0.58228042 |
| 124 | PLK1 | 0.57536407 |
| 125 | AURKA | 0.57482090 |
| 126 | MAPK12 | 0.57056447 |
| 127 | STK4 | 0.56686644 |
| 128 | PRKG2 | 0.55982919 |
| 129 | TSSK6 | 0.55495908 |
| 130 | SCYL2 | 0.54859004 |
| 131 | NUAK1 | 0.53906792 |
| 132 | CHUK | 0.53692924 |
| 133 | STK10 | 0.51827569 |
| 134 | CDK9 | 0.51314872 |
| 135 | CDK4 | 0.51055471 |
| 136 | STK24 | 0.50865758 |
| 137 | HCK | 0.49255202 |
| 138 | GRK6 | 0.48432023 |
| 139 | MAP3K11 | 0.46747066 |
| 140 | MET | 0.46407613 |
| 141 | MAPK7 | 0.46365185 |
| 142 | MYLK | 0.45368893 |
| 143 | BRAF | 0.44637819 |
| 144 | PDK2 | 0.44255448 |
| 145 | NEK9 | 0.43942142 |
| 146 | PRKCD | 0.43532222 |
| 147 | CDK7 | 0.42937326 |
| 148 | TESK1 | 0.42855558 |
| 149 | STK38L | 0.42834658 |
| 150 | TTK | 0.42427823 |
| 151 | EPHA3 | 0.41840650 |
| 152 | KSR2 | 0.41787027 |
| 153 | MAP3K10 | 0.41691160 |
| 154 | CHEK2 | 0.41299728 |
| 155 | PAK2 | 0.40973411 |
| 156 | NME1 | 0.40853077 |
| 157 | TRPM7 | 0.40268779 |
| 158 | MAP3K13 | 0.40197079 |
| 159 | ACVR1B | 0.39896199 |
| 160 | MAP2K4 | 0.39853637 |
| 161 | PRKCE | 0.39486516 |
| 162 | PAK1 | 0.39467996 |
| 163 | RIPK4 | 0.37284723 |
| 164 | HIPK2 | 0.36916869 |
| 165 | SGK2 | 0.36793470 |
| 166 | TESK2 | 0.36379087 |
| 167 | MST4 | 0.34485987 |
| 168 | RPS6KA6 | 0.34245896 |
| 169 | DYRK1B | 0.34178234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 2.95732937 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 2.75085429 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 2.72792423 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.52365997 |
| 5 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.52087665 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.35012639 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.20770544 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.20158015 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.15742163 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.08502308 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.08491863 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.07659569 |
| 13 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.04991618 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04532948 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 2.01438633 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88739123 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.88371733 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.87299830 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.81131161 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.75614306 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68468406 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.67720068 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.61644017 |
| 24 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.60159409 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58216652 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.57279636 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 1.55284389 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.51355549 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51252308 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48711769 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45410267 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.43273775 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.42313641 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.41827640 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41703136 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40461978 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.37805275 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.37012341 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.36188256 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.34789478 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.33383351 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31969204 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27668535 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24644683 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24544415 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 1.24322305 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23960040 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23009550 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20157467 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.19961579 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.19902802 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18633580 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17670853 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14883434 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 1.11809748 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09860627 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07223172 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07064567 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06547953 |
| 60 | Asthma_Homo sapiens_hsa05310 | 1.05645959 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04923564 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04072815 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03880685 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03319178 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03275861 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02580358 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00312600 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00032962 |
| 69 | * Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99126246 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98558277 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97785365 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.96824935 |
| 73 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96246325 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94283993 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.94142793 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.92460117 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.91743206 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91695051 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.91303250 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91059542 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90762117 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.89867869 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89177945 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88008056 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87016936 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86757917 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86589651 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.86187209 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85805828 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.84677882 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84204615 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83462056 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.83204550 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81930446 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80184555 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78710573 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75055252 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.74638251 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74340569 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73839097 |
| 101 | Nicotine addiction_Homo sapiens_hsa05033 | 0.73618841 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73456990 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73340944 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.73167807 |
| 105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69695285 |
| 106 | Tuberculosis_Homo sapiens_hsa05152 | 0.68476784 |
| 107 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65831950 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.65305501 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.64739773 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62134986 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61797926 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61172618 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60757492 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60494176 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60323943 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60292848 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.59459940 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59012065 |
| 119 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55966625 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55869516 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.54308108 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53697712 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53312837 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52105194 |
| 125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51960338 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51695574 |
| 127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51155192 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50296767 |
| 129 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49973775 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49958790 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49468926 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49324478 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48954806 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48485376 |
| 135 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47895277 |
| 136 | RNA transport_Homo sapiens_hsa03013 | 0.47528610 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46839328 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45688621 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44248032 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42331348 |
| 141 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42311659 |
| 142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41382226 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.41328249 |
| 144 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41254015 |
| 145 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41119189 |
| 146 | Salmonella infection_Homo sapiens_hsa05132 | 0.40216577 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39286164 |
| 148 | Hepatitis B_Homo sapiens_hsa05161 | 0.38911998 |
| 149 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37292620 |
| 150 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34846309 |
| 151 | Morphine addiction_Homo sapiens_hsa05032 | 0.33755087 |
| 152 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33349691 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33006366 |
| 154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32991177 |
| 155 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31263227 |
| 156 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.29804294 |
| 157 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28760097 |
| 158 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.27006743 |

